Patents Assigned to SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED
  • Patent number: 11325937
    Abstract: The present invention discloses a glycoside compound represented by Formula III, and a preparation method, a composition, use and an intermediate thereof. The glycoside compound provided in the present invention has simple preparation method, can significantly increase the expression of VEGF-A mRNA, and is effective in promoting the angiogenesis. This provides a reliable guarantee for the development of drugs with pro-angiogenic activity for treating cerebral infarction cerebral stroke, myocardial infarction, and ischemic microcirculatory disturbance of lower limbs.
    Type: Grant
    Filed: May 7, 2019
    Date of Patent: May 10, 2022
    Assignee: SHANGHAI HUTCHISON PHARMACEUTICALS LIMITED
    Inventors: Guoqiang Lin, Jiange Zhang, Ping Tian, Chenguo Feng, Changsen Zhan, Junjie Zhou